Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.23.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Schedule of Anti-dilutive Securities

These following common stock equivalents were excluded in the computation of the net loss per share because their effect is anti-dilutive:

  

   

June 30,

2023

   

June 30,

2022

 
    (Unaudited)     (Unaudited)  
Options to purchase common stock     3,737,952       302,500  
Warrants to purchase common stock     9,148,880       2,337,274  
Unvested restricted common stock     -       488,429  
Total anti-dilutive securities     12,886,832       3,128,203